Don’t miss the latest developments in business and finance.

Ajanta Pharma secures final approval for 3 ANDAs

Image
Capital Market
Last Updated : Aug 04 2015 | 11:04 AM IST

From USFDA

Ajanta Pharma has received final approval for its 3 ANDAs (Abbreviated New Drug Application) by US FDA (United States Food and Drug Administration) -

Montelukast Tablets, 10mg
Montelukast Sodium Chewable Tablets, 4mg & 5mg and
Montelukast oral granules.

Powered by Capital Market - Live News

More From This Section

First Published: Aug 04 2015 | 10:19 AM IST

Next Story